ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:10 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 230
Drug details and screening numbers
Drug Name: GSK429286A
Drug ID: 230
Synonyms:
Brand name:
Target: ROCK2
Number of cell lines screened: 926
Screening concentration range(s): 0.078125 to 20 uM and 0.04 to 10.24 uM
Statistically significant associations identified = 5
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a210 |
loss_cnaPANCAN15 |
230 |
1 |
1 |
GSK429286A |
ROCK2 |
22 |
901 |
3.00, 2.33 |
4.77 |
3.91 |
-0.862 |
0.73 . |
0.73 . |
0.6 . |
9.37e-05 |
2.3e-54 |
9.07e-01 |
7.4 |
a221 |
loss_cnaPANCAN13 |
230 |
1 |
1 |
GSK429286A |
ROCK2 |
20 |
903 |
3.00, 2.33 |
4.77 |
3.9 |
-0.867 |
0.73 . |
0.74 . |
0.56 . |
1.14e-04 |
2.43e-54 |
9.07e-01 |
8.5 |
a264 |
loss_cnaPANCAN14 |
230 |
1 |
1 |
GSK429286A |
ROCK2 |
22 |
901 |
3.00, 2.33 |
4.77 |
3.94 |
-0.829 |
0.7 . |
0.71 . |
0.56 . |
1.75e-04 |
2.72e-54 |
9.07e-01 |
11 |
a332 |
loss_cnaPANCAN16 |
230 |
1 |
1 |
GSK429286A |
ROCK2 |
15 |
908 |
3.00, 2.33 |
4.77 |
3.69 |
-1.08 |
0.91 . |
0.91 . |
0.76 . |
3.01e-04 |
3.15e-54 |
9.07e-01 |
15 |
a464 |
IDH1_mut |
230 |
1 |
1 |
GSK429286A |
ROCK2 |
4 |
919 |
3.00, 2.33 |
4.76 |
3.05 |
-1.71 |
1.4 * |
1.4 * |
1 * |
6.02e-04 |
3.8e-54 |
9.07e-01 |
21 |
All-tests volcano plot